1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Relapsing Polychondritis: new trials by email Literature Review of Relapsing Polychondritis trials Research Report on Relapsing Polychondritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tocilizumab for Relapsing Polychondritis Tocilizumab - Relapsing Polychondritis | Phase 2 | Withdrawn | McMaster Children's Hospital | 2010-05-01 | 2014-05-13 |
Inflammation (1) · Polychondritis, Relapsing (1)
Cartilage Diseases (1) · Connective Tissue Diseases (1) · Musculoskeletal Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin and Connective Tissue Diseases (1)
tocilizumab (1)
McMaster Children's Hospital (1)
Canada (1)